Server: Netscape-Commerce/1.1
Date: Thursday, 18-Dec-97 18:21:18 GMT
Last-modified: Thursday, 30-Oct-97 15:29:01 GMT
Content-length: 10206
Content-type: text/html

<!DOCTYPE HTML PUBLIC "-//SQ//DTD HTML 2.0 HoTMetaL + extensions//EN">

<HTML>
  
  <HEAD>
    <TITLE>Press Releases for OraVax Inc.</TITLE>
  </HEAD>
  
  <BODY BACKGROUND="../graphics/circleback.gif" BGCOLOR="#ffffff">
    <CENTER><IMG SRC="../graphics/logo.gif" WIDTH="353" HEIGHT="121"></CENTER>
    <CENTER>
    <TABLE WIDTH="90%" BORDER="0" CELLSPACING="5">
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="10_29_97.html">10/29/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax, Inc. to Conduct Phase III
        Clinical Trial for Respiratory Syncytial Virus in Infants in Winter
        1998-1999</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="10_23_97.html">10/23/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax, Inc. Reports 1997 Third Quarter
        Results
        <BR>-- Company Enters Yellow Fever U.S. Marketing and Distribution
        Agreement with Evans Medical Limited and Acquires ChimeriVax<FONT SIZE="-1"><SUP>TM</SUP></FONT>
        Technology Platform --</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="10_20_97.html">10/20/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">NIH Awards OraVax Phase II SBIR Grant for
        the Clinical Development of New Treatments for <I>Clostridium difficile</I>
        Associated Disease</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="09_29_97.html">09/29/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax and Evans Medical Sign U.S.
        Marketing and Distribution Agreement for Yellow Fever Vaccine
        <BR>-- OraVax To Assist With U.S. Registration &#150;</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="09_16_97.html">09/16/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax Acquires Chimeric Vaccine
        Technology from St. Louis University
        <BR>-- Patent Filing Covers a New Class of Single-Dose Viral Vaccines
        --</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="07_30_97.html">07/30/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax, Inc. Announces 1997 Second
        Quarter and Six Month Results</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="04_25_97.html">04/25/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax, Inc. Announces 1997 First Quarter
        Results</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="04_04_97.html">04/04/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax, Inc. Adopts Shareholder Rights
        Plan</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="04_03_97.html">04/03/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax Announces Reorganization; Reduces
        Operating Costs
        <BR>--Robert J. Gerety, M.D., Ph.D., Named Vice President of
        Development and Regulatory Affairs--</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD VALIGN="TOP" ALIGN="LEFT"><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="03_19_97.html">03/19/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax Reports Results from Phase III
        Trial of HNK20 Nosedrop for Respiratory Syncytial Virus in Infants</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD VALIGN="TOP" ALIGN="LEFT"><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="03_10_97.html">03/10/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax names C. Boyd Clarke, President of
        U.S. Bioscience, to Board of Directors.
        <BR>-- Engineered Joint Venture Between Merck and Pasteur-M&eacute;rieux
        --</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD VALIGN="TOP" ALIGN="LEFT"><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="03_03_97.html">03/03/97</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax Reports Fourth-Quarter and
        Year-End results
        <BR> -- Clinical Progress in Two Lead Programs Highlight Year --</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="11_25_96.html">11/25/96</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">Complete <I>H. Pylori</I>&nbsp;Genome
        Sequence Licensed to OraVax And Pasteur M&eacute;rieux Connaught in
        Exclusive agreement with MedImmune and Human Genome Sciences for
        Development of Novel Vaccines</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="11_14_96.html">11/14/96</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax Grants bioM&eacute;rieux Vitek
        License to CagA Antigen For <I>H. pylori</I> &nbsp;In Vitro Diagnostic
        Tests
        <BR> -- Out-Licensing Strategy Complements Core Vaccine <NOBR>Development
        --</NOBR></TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="10_23_96.html">10/23/96</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">Oravax Reports 1996 Third Quarter Results
        <BR>-- Successful Phase II Trial of Oral Therapeutic Vaccine Against
        <I>H. pylori</I>&nbsp;and Progress in Phase III Trial of HNK-20
        Highlight <NOBR>Quarter --</NOBR></TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="10_17_96.html">10/17/96</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax and Pasteur M&eacute;rieux
        Connaught Demonstrate Reduction of <I>H. pylori</I>&nbsp;Infection in
        Subjects Receiving Oral Vaccine
        <BR>-- Clinical Study Demonstrates Immune Responses and Reduced <I>H.
        pylori</I>&nbsp;Infection --</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="09_26_96.html">09/26/96</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax Updates Investors at Cowen &amp;
        Company's 11th Annual Biotechnology Conference
        <BR> -- Phase 2 safety and immunogenicity study of <I>H. pylori</I>&nbsp;
        oral vaccine complete; data to be presented at October <I>H. pylori</I>&nbsp;
        conference --</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" ALIGN="BOTTOM" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="08_07_96.html">08/07/96</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax, Inc. Reports 1996 Second Quarter
        Results
        <BR> -- Commencement of Phase 3 trials and regional marketing
        partnership for HNK20 highlight quarter --</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" ALIGN="BOTTOM" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="08_05_96.html">08/05/96</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">U.S. Patent Issues For OraVax, Inc.'s
        Oral Treatment of <I>H. pylori</I>&nbsp; Infection</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" ALIGN="BOTTOM" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="07_08_96.html">07/08/96</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax, Inc. Announces Exercise of
        Over-Allotment Option</TD>
      </TR>
      <TR>
        <TD COLSPAN="3"><HR></TD>
      </TR>
      <TR>
        <TD><IMG SRC="../graphics/circlebackbullet.gif" ALIGN="BOTTOM" WIDTH="36" HEIGHT="36"></TD>
        <TD VALIGN="TOP" ALIGN="LEFT"><A HREF="06_26_96.html">06/26/96</A></TD>
        <TD VALIGN="TOP" ALIGN="LEFT">OraVax, Inc. Announces Public Offering of
        2.0 Million Shares of Common Stock</TD>
      </TR>
    </TABLE>
    <BR>
    <BR><A HREF="../index.html">OraVax Home Page|</A>
    <A HREF="../annuals.html">Annual Report Highlights| </A><A HREF="../contact/index.html">Contacting
      Us</A>
    <BR><A HREF="http://www.nasdaq.com/scripts/html3/fquote.idc?symname=orvx">Current
      Stock Price|</A> <A HREF="../about/index.html">About OraVax</A></CENTER> 
  </BODY>
</HTML>
